The Effects of Functional Strengthening in Spastic Cerebral Palsy
The Effects of Progressive Functional Ankle Strengthening in Children With Unilateral and Bilateral Spastic Cerebral Palsy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06500
- Gazi University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Accepting to participate in the study,
- Being between 5-15 years old,
- Having a diagnosis of Spastic Cerebral Palsy,
- Being level I-II according to GMFCS,
Exclusion Criteria:
- Having limited cooperation which prevents participation in the study,
- Refusing to participate in the study,
- Having an orthopedic disorder or systemic illness which prevents movement in the lower extremities,
- Having a Botulinum toxin application in the last 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Dorsiflexor Muscle Strengthening Group
The children in this group will receive functional exercises aiming to strengthen their dorsiflexor muscles alongside standard functional progressive strengthening exercises.
|
The children in each group will receive 6 weeks of functional strengthening exercises targeting each muscle group according to the arm they are included in.
|
|
Active Comparator: Plantarflexor Muscle Strengthening Group
The children in this group will receive functional exercises aiming to strengthen their plantarflexor muscles alongside standard functional progressive strengthening exercises.
|
The children in each group will receive 6 weeks of functional strengthening exercises targeting each muscle group according to the arm they are included in.
|
|
Active Comparator: Dorsiflexor and Plantarflexor Muscle strengthening Group
The children in this group will receive functional exercises aiming to strengthen both their dorsiflexor and plantarflexor muscles alongside standard functional progressive strengthening exercises.
|
The children in each group will receive 6 weeks of functional strengthening exercises targeting each muscle group according to the arm they are included in.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pediatric Balance scale
Time Frame: Change of The Pediatric balance scale at 6 weeks.
|
The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in children.
The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points.
|
Change of The Pediatric balance scale at 6 weeks.
|
|
Surface Electromyography (sEMG)
Time Frame: Change of sEMG data at 6 weeks.
|
Surface electromyography is a non-invasive procedure involving the detection, recording and interpretation of the electric activity of groups of muscles during activity.
The procedure is performed using electrodes placed on the skin surface over the muscles to be tested.
sEMG is also used to assess the effects of rehabilitation programs and evaluate muscular function in children with cerebral palsy.
Due to its non-invasive properties it is safely and widely used in the pediatric population.
|
Change of sEMG data at 6 weeks.
|
|
The Six minute walk test
Time Frame: Change of 6 MWT at 6 weeks.
|
The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise.
The test has been shown to be valid and reliable in children with Cerebral Palsy.
|
Change of 6 MWT at 6 weeks.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Bulent Elbasan, Assoc. Prof., Gazi University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 465426
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.